Retrospective study on the prognostic prediction of inflammatory markers and the C-reactive protein/albumin ratio in first-line immunotherapy for advanced HER2 negative gastric cancer patients
Inflammatory markers (i.e., the SII, NLR, PLR, and CAR) can be used to predict the prognosis of HER2 negative advanced gastric cancer patients undergoing first-line immunotherapy.
Authors
- Zijian Sun (ORCID: https://orcid.org/0000-0002-3116-2104)
- Yan Kui Sun (ORCID: https://orcid.org/0000-0001-8916-9598)
- Guoren Zhou (ORCID: https://orcid.org/0000-0001-5344-8480)
- Xinnian Yu (ORCID: https://orcid.org/0000-0001-9441-8587)
- Yan F (ORCID: https://orcid.org/0000-0002-5066-2884)
Institutions
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21037/tcr-2025-192
- Citations
- 4
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.18